Frozen and freeze-dried products for Fecal Microbiota Transplantation (FMT) are nearly as effective as fresh product at treating patients with Clostridium difficile (C-diff) infection, according to researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health and Kelsey Research Foundation. A new study, which proves that a pill form of treatment could be effective and more convenient for patients and physicians, was published in the most recent issue of Alimentary Pharmacology & Therapeutics.
C-diff is a bacterium that causes inflammation of the colon. People infected with the bacteria can have recurrent diarrhea that lasts months or even years. It is the No. 1 hospital-acquired infection in the United States and leads to 29,000 deaths each year, according to the Centers for Disease Control and Prevention. The illness most commonly affects people in hospitals and nursing homes who are taking antibiotics and may have an underlying medical condition.
FMT is a procedure in which a doctor extracts bacteria from fecal matter from a healthy donor, mixes the bacteria in a solution and transfers the microbiota to a person with C-diff via colonoscopy, endoscopy, sigmoidoscopy or enema. The study shows that the fecal microbiota can be frozen or freeze-dried (like instant coffee). The procedure replenishes good bacteria killed by antibiotics in the microbiome.
For the study, UTHealth and Kelsey Research Foundation investigators enrolled 72 patients who had at least three bouts of recurrent C-diff in a clinical trial and treated them with either fresh, frozen or freeze-dried FMT product via colonoscopy. Fresh FMT product produced a 100 percent cure rate among participants; frozen product produced an 83 percent cure rate and freeze-dried product produced a 69 percent cure rate.
Frozen and fresh product fully restored the microbiota diversity among participants within seven days after treatment. Researchers saw some improvement in microbiota diversity among participants treated with freeze-dried product after seven days and full restoration of healthy bacteria within 30 days.
“This is the first study to show that frozen and freeze-dried microbiota are as good as fresh material, so that we never have to use fresh again. It’s a logistical nightmare to use fresh product. If we were going to treat you today, a donor would have come in two hours before, we would have already isolated the sample and then we would have to administer it the same day. A pill form of the product could make all of this easier,” said Herbert L. DuPont, M.D., senior author and director of the Center for Infectious Diseases at UTHealth School of Public Health.
DuPont co-directs the FMT program with Zhi-Dong Jiang, M.D., Dr.P.H., associate professor in the Department of Epidemiology, Human Genetics and Environmental Sciences at the School of Public Health. DuPont is also the president and CEO of Kelsey Research Foundation.
“Freeze-dried product can be put into a pill that can be given orally, which is much more convenient for patients and physicians,” said DuPont, who is currently testing the safety and efficacy of a pill version of the product.
One of the participants in the clinical trial, John Siebert, was on vacation with his family in California when he contracted C-diff in August 2014. The 66-year-old, who is a professor of agricultural economics at Texas A&M University, sought medical care as soon as he returned to Texas but was stunned that his doctors did not know how to treat the condition in a lasting way. After four months and three bouts of C-diff that left him fighting for his life, Siebert was at a loss.
“It’s extremely painful and debilitating because you can’t ever really be far from a bathroom. I had really bad cramps and I ate a lot less because I didn’t want to aggravate things,” said Siebert, who lost nearly 20 pounds and missed a month of work.
Eventually, Siebert found DuPont and Jiang, who were enrolling patients in their FMT clinical trial. Siebert immediately signed up and had the procedure done in early December. Siebert felt mostly recovered by Christmas and was back to his normal self by March 2015.
“It was a miracle! I love teaching and I can’t tell you what it was like to be healthy again, to be able to do my job and not retire before I was ready,” said Siebert.
Siebert’s struggle to find a permanent cure to C-diff is not uncommon. Physicians typically treat C-diff with antibiotics, which can kill one form of the bacteria, the toxins. However, C-diff spores are much harder to kill and once the antibiotics have destroyed both good and bad bacteria in the gut, the remaining spores can release additional toxins. There is a 50 percent chance that a person who has C-diff will get a recurrent infection because of those toxins.
Jiang was first author of the paper. Co-authors from UTHealth included Goo Jun, Ph.D.; Craig Hanis, Ph.D.; Andrew DuPont, M.D.; Shi Ke, M.D., and Manasi Shah, Ph.D.
@bigdock Great news! Sending you our best wishes.
If you love citrus, you will really love these recipes with options from salad to stir-fry.
Women with darker skin can get #skincancer, too. Our Dr. Susan Chon shares what you should know: https://t.co/02BBg4YNmw @thirdAGE #endcancer
Overcoming #cancer shapes 3 MD Anderson employees’ perspectives: https://t.co/cUt1DJj9F1 #endcancer https://t.co/FmZgRjUw0b
University of Houston@UHouston
Legacy is planting seeds in a garden you never get to see. Tonight we’re celebrating the legacy of @UHValentiSchool. Thank you @seguntheprogram for being MC and @jdbalart for the Impact Award https://t.co/tBmWEylyiU
Entering a new era: learn more about TMC3, the new translational research campus. https://t.co/pCLaez3zts
Be a part of the nation's largest autism research study. Get in-person help with signing up for SPARK for Autism at the Houston Museum of Natural Science during their sensory friendly event April 28. http://bit.ly/SPARKevents
An Army Veteran confronts his own trauma with a camera https://t.co/qoMYFKKZjq via @nytimes
In this interview with @ktrhnews, Dr. James Langabeer of @UTHealth_SBMI and @UTEmergencyMed discusses the decline in prescriptions for addictive painkillers: https://t.co/CMlYcJngA4
At 10 months old, David was so weak and behind in development that he couldn't even sit up. But now the bubbly 4-year-old is growing fast and swinging baseball bats. Read about his miraculous journey w/@UTPhysicians CARE Clinic. https://t.co/3chQLYaeex #ManyFacesOfUTHealth https://t.co/LZptSVgsDY
RT @UTCVSurgery: Another great free medical screening service brought to you by @UTPhysicians! Check out Dr Stuart Harlin on this morning’s…
Veterans serving Veterans: Researchers who served. This @usairforce Veteran volunteered as a pararescueman in Vietnam, and then went on to serve others with a career in orthopedic research. https://t.co/2NQHhSTmQx via @VeteransHealth on #VAntagePoint
At 10 months old, David was so weak and behind in development that he couldn't even sit up. But now the bubbly 4-year-old is growing fast and already swinging baseball bats. Read about his miraculous journey with the UT Physicians CARE Clinic. #ManyFacesOfUTHealth
Today’s #VeteranOfTheDay is Navy Veteran Willard Knockum Jr. Willard served from 1964 to 1971 during the Vietnam War. Willard joined the Navy in 1964. He was trained in counterinsurgency and survival surveillance reconnaissance and weapons at the Marine Base Camp in Pendleton, California. He became a Boatswain Mate, a role that fulfills a variety of tasks such as lookout duty, training and directing maintenance duties, damage control, operating and maintaining equipment and more. Willard also participated in North Atlantic Treaty Organization and anti-submarine warfare exercises. Willard served on the destroyer USS Fox 779 before he deployed to Vietnam in 1969 during the Vietnam War where he served in Saigon and Dong Tam. He was assigned to Military Assistance Command, a group of assault river boats that patrolled hostile waters around the Army Base at Dong Tam. For his service, Willard was awarded the Vietnam Service Medal and the Republic of Vietnam Campaign Medal. Willard now lives in Folsom, Louisiana as a retired United Postal Service mail handler. Thank you for your service, Willard!
Today’s #VeteranOfTheDay is @USNavy Veteran Willard Knockum, Jr https://t.co/7lDPTdSI86